{"id":"https://openalex.org/W4403724279","doi":"https://doi.org/10.14309/01.ajg.0001034448.99555.33","title":"S1270 Efficacy and Outcomes of Upadacitinib (Rinvoq) Use in Hospitalized Crohn's Disease Patients","display_name":"S1270 Efficacy and Outcomes of Upadacitinib (Rinvoq) Use in Hospitalized Crohn's Disease Patients","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403724279","doi":"https://doi.org/10.14309/01.ajg.0001034448.99555.33"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0001034448.99555.33","doi":"https://doi.org/10.14309/01.ajg.0001034448.99555.33","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001034448.99555.33","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065059273","display_name":"Jawad Bouhamdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]},{"id":"https://openalex.org/I4210114445","display_name":"Michigan Medicine","ror":"https://ror.org/01zcpa714","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210114445"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jawad Bouhamdan","raw_affiliation_strings":["University of Michigan Health, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan Health, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085948854","display_name":"Jeffrey Aaron Berinstein","orcid":"https://orcid.org/0000-0001-7631-9665","observed_orcids":["https://orcid.org/0000-0001-7631-9665"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A. Berinstein","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI","institution_ids":["https://openalex.org/I27837315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5065059273"],"corresponding_institution_ids":["https://openalex.org/I27837315","https://openalex.org/I4210114445"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"119","issue":"10S","first_page":"S905","last_page":"S905"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/upadacitinib","display_name":"upadacitinib","score":0.9679999947547913},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":0.9879999756813049},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.875},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.7839999794960022},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.8069999814033508},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.5460000038146973},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.5450000166893005},{"id":"https://openalex.org/keywords/early-treatment-initiation","display_name":"early treatment initiation","score":0.4869999885559082},{"id":"https://openalex.org/keywords/post-discharge-outcomes","display_name":"post-discharge outcomes","score":0.5830000042915344},{"id":"https://openalex.org/keywords/hospital-readmission","display_name":"hospital readmission","score":0.4259999990463257},{"id":"https://openalex.org/keywords/biologic-naive-patients","display_name":"biologic-naive patients","score":0.4429999887943268},{"id":"https://openalex.org/keywords/biologic-experienced-patients","display_name":"biologic-experienced patients","score":0.6159999966621399},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9884663820266724},{"id":"https://openalex.org/C2779280984","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn's disease","level":3,"score":0.6256232857704163},{"id":"https://openalex.org/C2992200296","wikidata":"https://www.wikidata.org/wiki/Q1472","display_name":"Crohn disease","level":4,"score":0.43463563919067383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42139115929603577},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38510680198669434},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.36323827505111694}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0001034448.99555.33","doi":"https://doi.org/10.14309/01.ajg.0001034448.99555.33","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001034448.99555.33","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414884015","https://openalex.org/W7125152558","https://openalex.org/W4318539711","https://openalex.org/W4393899943","https://openalex.org/W7125185116","https://openalex.org/W4391165565","https://openalex.org/W4318578762","https://openalex.org/W4391162073","https://openalex.org/W4414933278","https://openalex.org/W4400192907"],"abstract_inverted_index":{"Introduction:":[0],"Inflammatory":[1],"bowel":[2],"disease":[3,60,212,251],"encompasses":[4],"a":[5,31,64,83,96,124,180],"group":[6],"of":[7,47,53,67,78,89,98,107,110,117,133,147,160,184,190,201,209,230,265,303,319,345,348,355],"inflammatory":[8],"gastrointestinal":[9],"diseases":[10],"that":[11,322],"are":[12],"often":[13],"relapsing":[14],"and":[15,19,23,38,69,74,91,119,135,228,241,262,350,373],"remitting":[16],"in":[17,34,80,86,129,138,149,162,193,203,285,308,339,362],"nature":[18],"include":[20,220],"ulcerative":[21],"colitis":[22],"Crohn\u2019s":[24],"Disease":[25],"(CD).":[26],"CD":[27,99,118,134,151,165,202,240,287,320,365],"affects":[28],"over":[29,206],"half":[30],"million":[32,41],"individuals":[33,42],"the":[35,45,51,87,105,115,145,158,188,199,207,221,235,293,301,316,369],"United":[36,71],"States,":[37],"nearly":[39],"4.9":[40],"worldwide.":[43],"Before":[44],"development":[46],"biologic":[48,111,357],"agents":[49],"for":[50,131,171,198,223,239,250,272,306,371],"treatment":[52,132,200],"CD,":[54,90,346,349],"many":[55],"patients":[56,166,173,205,237,267,321],"struggled":[57],"to":[58,63,113,156,259,314,336],"achieve":[59],"control":[61],"leading":[62],"high":[65],"rate":[66],"morbidity":[68],"mortality.":[70],"States":[72],"Food":[73],"Drug":[75],"Admnistration":[76],"approval":[77,305],"Infliximab":[79],"1998":[81],"marked":[82],"revolutionary":[84],"change":[85],"management":[88],"biologics":[92],"have":[93,103],"since":[94],"become":[95],"staple":[97],"treatment.":[100],"Recent":[101],"studies":[102,143],"demonstrated":[104],"benefit":[106,325],"early":[108],"initiation":[109],"therapy":[112],"prevent":[114],"progression":[116],"associated":[120],"complications.":[121],"Upadacitinib":[122,148,161,195,226,256,290,359],"is":[123,136,179,298,312],"Janus":[125],"kinase":[126],"inhibitor":[127],"approved":[128],"2023":[130],"effective":[137],"achieving":[139],"remission.":[140],"However,":[141],"no":[142],"evaluate":[144,157],"use":[146,307,328,354],"hospitalized":[150,164,204,238,286,364],"patients.":[152],"Our":[153,177,279,296],"study":[154,178,297],"aims":[155],"efficacy":[159,340],"treating":[163,363],"as":[167,169],"well":[168],"outcomes":[170,284],"these":[172],"following":[174,216],"discharge.":[175,217],"Methods:":[176],"retrospective":[181],"chart":[182],"review":[183],"19":[185,236],"cases":[186],"at":[187,275],"University":[189],"Michigan":[191],"Hospital":[192],"which":[194],"was":[196,214],"initiated":[197,242],"age":[208],"18.":[210],"Patient":[211],"activity":[213],"monitored":[215],"Primary":[218],"endpoints":[219],"need":[222,370],"surgical":[224,374],"intervention,":[225],"discontinuation,":[227],"frequency":[229],"steroid-requiring":[231],"flares.":[232],"Results:":[233],"Among":[234],"on":[243,292,342],"Upadacitinib,":[244],"21%":[245],"(4/19)":[246],"required":[247,313],"post-discharge":[248],"surgery":[249],"control,":[252],"37%":[253],"(7/19)":[254],"had":[255],"discontinued":[257],"due":[258],"uncontrolled":[260],"disease,":[261],"85%":[263],"(6/7)":[264],"eligible":[266],"did":[268],"not":[269],"require":[270],"steroids":[271,372],"persistent":[273],"symptoms":[274],"90-day":[276],"follow-up.":[277],"Conclusion:":[278],"initial":[280],"results":[281],"suggest":[282],"favorable":[283],"treated":[288],"with":[289],"based":[291,341],"primary":[294],"endpoints.":[295],"limited":[299],"by":[300],"recency":[302],"Upadacitinib's":[304],"CD.":[309],"More":[310],"research":[311],"describe":[315],"specific":[317],"population":[318],"would":[323],"most":[324],"from":[326],"its":[327],"in-hospital.":[329],"Specifically,":[330],"further":[331],"analyses":[332],"should":[333],"be":[334],"performed":[335],"investigate":[337],"differences":[338],"demographics,":[343],"geography":[344],"severity":[347],"prior":[351],"or":[352],"concurrent":[353],"alternative":[356],"agents.":[358],"shows":[360],"promise":[361],"patients,":[366],"potentially":[367],"reducing":[368],"interventions.":[375]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2024-10-25T00:00:00"}